Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.

Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to re-imagine the domestic production of ...

Its new products rely on foreign supplies. Phlow Corp. won White House backing to revitalize domestic manufacturing of active pharmaceutical ingredients March 9, 2022 More than 3 years ago 7 min ...

From the Winter 2021/2022 issue of Inc. Magazine Eric Edwards, co-founder and CEO of Phlow. Photo: Courtesy company. Illustration: Inc. Magazine ...